FDA Inspection 1087318 — LifeStream Blood Bank
The FDA completed an inspection of LifeStream Blood Bank on March 27, 2019 in Riverside, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 27, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Riverside, CA (United States)